Dong Xie
CFO, Senior Vice President & DirectorMr. Dong Xie, also known as Tim, is Independent Non-Executive Director of Duality Biotherapeutics, Inc. from April 15, 2025. Mr. Xie serves as an Independent Non-Executive Director of China BlueChemical Ltd. He is CFO, Senior Vice President & Director of Here Group Limited (formerly known as QuantaSing Group Limited). Mr. Xie was CFO & Director of Here Group Limited (formerly known as QuantaSing Group Limited) from June 2022. He is senior vice president of Here Group Limited (formerly known as QuantaSing Group Limited) since October 2025. Since May 27, 2021. Prior to this, Mr. Xie had served as the Partner of capital market services at PGadvisory from March 2020 to December 2020. From January 2019 to March 2020, Mr. Xie served as the Chief Financial Officer at Renmai Technology Group. From September 2014 to December 2018, Mr. Xie served as the Chief Financial Officer and Company Secretary of Finup Financial Technology Group (Holdings) Co., Ltd. From April 2010 to September 2010, Mr. Xie served as a Vice President at CCB International (China) Co., Ltd. From November 2007 to March 2010 and from October 2010 to August 2014, Mr. Xie served as the associate Director at the merger and acquisition transaction service department of Deloitte China. Mr. Xie is a Chinese Certified Public Accountant, Certified Internal Auditor, Certified Tax Agent and holds the China Legal Professional Qualification. He received his bachelor’s degree in economics and master’s degree in global economics from Nankai University in June 2003 and June 2006, respectively and he started in September 2021 for the EMBA degree jointly offered by Guanghua School of Management of Peking University and Kellogg School of Management of Northwestern University.
公司職務
- 公司名稱Here Group Limited股票代碼HERE職務CFO, Senior Vice President & Director
- 公司名稱中海石油化學股份有限公司股票代碼03983職務Independent Non-Executive Director
